Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-127060
Filing Date
2024-11-14
Accepted
2024-11-14 16:10:29
Documents
76
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q bior-20240930.htm   iXBRL 10-Q 2488751
2 EX-31.1 bior-ex31_1.htm EX-31.1 17000
3 EX-31.2 bior-ex31_2.htm EX-31.2 17467
4 EX-32.1 bior-ex32_1.htm EX-32.1 14485
  Complete submission text file 0000950170-24-127060.txt   11172958

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT bior-20240930.xsd EX-101.SCH 1804578
79 EXTRACTED XBRL INSTANCE DOCUMENT bior-20240930_htm.xml XML 1720463
Mailing Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122
Business Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122 855-293-2639
BIORA THERAPEUTICS, INC. (Filer) CIK: 0001580063 (see all company filings)

EIN.: 273950390 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39334 | Film No.: 241462203
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)